Altace

GPTKB entity

Statements (40)
Predicate Object
gptkbp:instanceOf gptkb:brand
gptkb:drug
gptkbp:activeIngredient gptkb:ramipril
gptkbp:approvedBy 1991
gptkbp:ATCCode C09AA05
gptkbp:bioavailability 28%
gptkbp:CASNumber 87333-19-5
gptkbp:chemicalFormula C23H32N2O5
gptkbp:contraindication pregnancy
bilateral renal artery stenosis
history of angioedema
gptkbp:drugClass ACE inhibitor
gptkbp:eliminationHalfLife 13-17 hours
gptkbp:excretion urine
https://www.w3.org/2000/01/rdf-schema#label Altace
gptkbp:KEGGID D08602
gptkbp:legalStatus Rx-only
gptkbp:manufacturer gptkb:Pfizer
gptkbp:MedlinePlusID a692027
gptkbp:MeSH_ID D016123
gptkbp:metabolism liver
gptkbp:pregnancyCategory D (US)
gptkbp:pregnancyWarning can cause injury and death to the developing fetus
gptkbp:prescriptionStatus prescription only
gptkbp:proteinBinding 73%
gptkbp:PubChem_CID gptkb:CHEMBL1428
5464096
DB00178
gptkbp:routeOfAdministration oral
gptkbp:sideEffect dizziness
cough
hypotension
hyperkalemia
gptkbp:status FDA approved
gptkbp:UNII 497Y77246T
gptkbp:usedFor heart failure
hypertension
reduction of cardiovascular risk
gptkbp:bfsParent gptkb:King_Pharmaceuticals
gptkbp:bfsLayer 5